Second Virus Wave Fears Create Growing Demand for Testing, Treatments and Vaccine Candidates
Vaxart, Inc. (VXRT)
Last vaxart, inc. earnings: 3/19 04:01 pm
Check Earnings Report
Company Research
Source: PR Newswire
NEW YORK, July 13, 2020 /PRNewswire/ -- Coronavirus cases continue to rise in the US this month as regulations lift, causing overambitious governors in several states to backpedal on previous claims. While the rest of the world prepares for a potential second wave, the US continues to struggle to get COVID-19 under control, calling forth urgent demand for rapid tests, treatments, and vaccine candidates. For the last several months, biotech companies big and small have been working to develop solutions to help curb the spread and treat those who have been infected. Vaxart, Inc. (NASDAQ:VXRT) is working on a potential vaccine, while Gilead Sciences Inc (NASDAQ:GILD) is focused on creating a treatment to shorten recovery time for severely ill COVID-19 patients. At the same time, Hologic, Inc. (NASDAQ:HOLX), Roche Holdings (OTCQX:RHHBY), and LexaGene Holdings Inc. (TSXV:LXG) (OTCQB:LXXGF) are creating COVID-19 tests that promise to deliver faster and more accurate results.WHO Applauds the
Show less
Read more
Impact Snapshot
Event Time:
VXRT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VXRT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VXRT alerts
High impacting Vaxart, Inc. news events
Weekly update
A roundup of the hottest topics
VXRT
News
- Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers [Yahoo! Finance]Yahoo! Finance
- Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating MothersGlobeNewswire
- Vaxart to Present at World Vaccine Congress Washington 2024 on April 3GlobeNewswire
- Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
VXRT
Earnings
- 11/2/23 - Beat
VXRT
Sec Filings
- 4/30/24 - Form 8-K
- 4/29/24 - Form ARS
- 4/29/24 - Form DEFA14A
- VXRT's page on the SEC website